CN102266481B - 一种治疗慢性脑供血不足的中药制剂 - Google Patents
一种治疗慢性脑供血不足的中药制剂 Download PDFInfo
- Publication number
- CN102266481B CN102266481B CN 201110193821 CN201110193821A CN102266481B CN 102266481 B CN102266481 B CN 102266481B CN 201110193821 CN201110193821 CN 201110193821 CN 201110193821 A CN201110193821 A CN 201110193821A CN 102266481 B CN102266481 B CN 102266481B
- Authority
- CN
- China
- Prior art keywords
- grams
- restrains
- chinese medicinal
- medicinal preparation
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 16
- 230000001684 chronic effect Effects 0.000 title claims abstract description 16
- 230000004087 circulation Effects 0.000 title abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 26
- 230000036770 blood supply Effects 0.000 claims description 13
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 230000007246 mechanism Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 5
- 206010022437 insomnia Diseases 0.000 abstract description 5
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 206010022998 Irritability Diseases 0.000 abstract description 3
- 208000009205 Tinnitus Diseases 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 231100000886 tinnitus Toxicity 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 206010013954 Dysphoria Diseases 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 206010027175 memory impairment Diseases 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229960004538 alprazolam Drugs 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗慢性脑供血不足的中药制剂,由以下中药加工配制而成:黄芪30克、葛根15克、桑寄生15克、丹参30克、生山楂9克、川芎9克、桂枝10克、麦冬12克、五味子6克、炒枣仁15克。取上述重量原料中药,经炮制后加1000ml水煎煮,药汁浓缩至200ml时捞渣过滤制成汤剂,一日一剂,两周一个疗程。本发明所述的中药制剂能够补血益气、舒筋通络,显著改善了心脑循环,提高了机体免疫力,同时具有抗炎、延缓衰老等功效,配伍合理,标本兼治,有效缓解了慢性脑供血不足患者的头晕、头沉、头痛、心烦、耳鸣、易怒、失眠多梦、记忆力减退、注意力不集中、疲乏感等症状。
Description
技术领域:
本发明涉及中药技术领域,尤其是一种治疗慢性脑供血不足的中药制剂。
背景技术:
生活中有很多人尤其是中老年人经常反复出现头晕、头沉、头痛的症状,同时伴有心烦、耳鸣、易怒、失眠多梦,记忆力减退、注意力不集中、疲乏感等,这些都是慢性脑供血不足的表现。据相关研究统计,中老年人群中有超过60%的人患有慢性脑供血不足,属于中老年人的多发病。国内、外大量研究还发现,在“脑梗死”和“老年痴呆症”的发病前期都长期有慢性脑供血不足的情况。以往多数患者应用西药治疗,短时间内可能有一定疗效,但西药多有副作用,长期应用部分药物可能产生依赖性。中药重在调理,副作用小,不易产生依赖性,可从总体上增强患者机体各方面功能,从而起到事半功倍的疗效。
发明内容:
本发明的目的在于提供一种可以明显改善慢性脑供血不足患者症状,提高患者生活质量的中药制剂。此制剂方便服用、安全有效。
本发明的技术方案是:一种治疗慢性脑供血不足的中药制剂,由以下中药加工配制而成:黄芪30克、葛根15克、桑寄生15克、丹参30克、生山楂9克、川芎9克、桂枝10克、麦冬12克、五味子6克、炒枣仁15克。取上述重量原料中药,经炮制后加1000ml水煎煮,药汁浓缩至200ml时捞渣过滤制成汤剂,一日一剂,两周一个疗程。
本发明配方中各药功效如下:
黄芪,补血养气,固本止汗。多用于气虚血亏,表虚自汗,四肢乏力,精神不足或久病衰弱,脾胃不壮。药理机制:主要有提高免疫功能,耐缺氧,降低血小板粘附,提高红细胞Na+泵活性,促进糖胺多糖合成及抑制癌细胞等作用。葛根,升阳解肌,透疹止泻,除烦止渴。药理机制:能改善微循环,扩张冠状动脉,增加脑和冠状动脉血流量,减慢心率,降低心肌耗氧指数而改善缺血心肌的代谢,还具有抗血栓素,提高高密度脂蛋白、抗血管痉挛和降低血小板聚集的作用。桑寄生,补益肝肾、强筋健骨、祛风湿、疗痹痛,药理机制:降压、利尿、扩张血管、抗惊厥、抗病毒、抗血栓的作用。丹参,活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神。药理机制:改善微循环、抗血小板的聚集和血栓形成,降低血液粘度、抑制大脑皮层,产生镇静作用、抗肿瘤、抗菌消炎、对体液及细胞免疫功能有较强的抑制作用。生山楂,消食健胃,行气散瘀。药理机制:促进消化、增强心肌收缩力、降压、降脂、抗氧化、抗菌、防癌、改善睡眠。川芎,活血行气、祛风止痛。药理机制:主要成分川芎嗪、阿魏酸具有清除氧自由基、钙拮抗、扩血管、抗血小板聚集、防止血栓形成、保护血管内皮细胞、调节免疫功能等作用。桂枝,发汗解肌,温经通脉。治风寒表证,肩背肢节酸疼,胸痹痰饮,经闭癥瘕。药理机制:抗菌、抗病毒、利尿。麦冬,养阴生津,润肺清心。药理机制:提高免疫力、抗菌、增强垂体肾上腺皮质系统功能、抗心律失常、扩外周血管、提高耐缺氧能力、降血糖。五味子,敛肺,滋肾,生津,收汗,涩精。药理机制:镇静、保肝、扩血管、延缓衰老、祛痰镇咳、改善免疫、抗溃疡。炒枣仁,养肝,宁心,安神,敛汗。药理机制:镇静、催眠、镇痛、抗惊厥、降温、降压。
本发明所述的中药制剂能够补血益气、舒筋通络,显著改善了心脑循环,提高了机体免疫力,同时具有抗炎、延缓衰老等功效,配伍合理,标本兼治,有效缓解了慢性脑供血不足患者的头晕、头沉、头痛、心烦、耳鸣、易怒、失眠多梦、记忆力减退、注意力不集中、疲乏感等症状,疗效显著。
本发明采用以上配方,具有以下临床治疗效果:
1.该配方摒弃了西药治疗慢性脑供血不足的弊端,疗效显著,且无明显毒副作用,不易产生依赖性。经临床治疗66例患者,全部患者症状具有所好转,其中显著改善的患者达64例(96.96%),尚未出现头痛、恶心、呕吐等不良反应。
2.此方克服了以往中药煎剂费时、费力、不易充分提取药物有效成分的缺点,粉碎后煎成汤药;分装为制剂,延长了保质期,患者易于服用。
用药注意事项:
1.孕妇及出血性疾病患者禁用,18岁以下患者尚无应用研究,不良反应不明。
2.用药期间忌油腻食物。
3.该药仅适用于慢性脑供血不足患者,脑血管病急性期仍需就诊医院正规治疗。
4.两周为一疗程,一疗程结束后,若病情需要可停用3-4天后再行下一疗程。
具体实施方式
实施例:一种治疗慢性脑供血不足的中药制剂,由以下中药加工配制而成:黄芪30克、葛根15克、桑寄生15克、丹参30克、生山楂9克、川芎9克、桂枝10克、麦冬12克、五味子6克、炒枣仁15克。取上述重量原料中药,经炮制后加1000ml水煎煮,药汁浓缩至200ml时捞渣过滤制成汤剂,一日一剂,两周一个疗程。
典型病例:
1.张XX,男,67岁 失眠多梦、周身乏力2年,加重1周。伴有便秘、口苦症状。查体:Bp160/100mmHg,神志清,言语流利,舌苔厚,心音低钝,双肺呼吸音粗,双下肢轻度凹陷性水肿。余查体无明显阳性体征。血胆固醇6.7mmol/L,血糖7.4mmol/L。既往曾应用“地西泮、阿普唑仑、刺五加”等药治疗,短期效果好,但对镇静药产生依赖,停药后症状反复。诊断为慢性脑供血不足,服用本发明制剂一个疗程后症状缓解,继续使用二个疗程治愈,患者排便明显改善,血压稳定在130/80mmHg左右,血脂正常,失眠、乏力症状消失,双下肢无水肿。
2.赵XX,女,54岁 头晕、心烦、多汗、易怒3年。伴有食欲差,易疲劳等症状。查体:Bp 155/95mmHg,心率76次/分,可闻及早搏,双肺呼吸音粗,腹软,肠鸣音2次/分。双侧眼底动脉硬化。心电图示频发房性早搏,ST-T异常。诊断为慢性脑供血不足,应用本发明药剂三个疗程后,复查心电图正常,血压125/70mmHg,双侧眼底动脉硬化好转。心烦、头晕、多汗症状消失,食欲明显改善,体力充沛。
3.李X,男,48岁 精力不集中、记忆力减退6个月。伴有情绪低落、多梦,有时感肢体麻木。查体:心肺腹正常,神志清,言语流利,反应稍迟钝,双手指尖麻木。经颅多普勒显示脑动脉硬化、各脑血管血流速度减慢。诊断为慢性脑供血不足,服用本发明中药制剂两个疗程后,复查经颅多普勒显示正常。患者情绪好转,未再出现肢体麻木,睡眠质量显著改善,记忆力增强。
4.程XX,女,58岁 头晕、头沉3月。平素体质差,常易感冒。查体:Bp180/90mmHg,神志清,言语流利,双肺呼吸音粗,可闻及少量湿性啰音,余未查及阳性体征。血沉35mm/h,胸片示支气管炎X线表现。诊断患有轻度慢性脑供血不足,服用本发明制剂一疗程后,患者头痛、头晕症状消失,血压125/80mmHg,复查胸片正常,血沉10mm/h,巩固治疗二个疗程痊愈,无复发。
5.方XX,男,70岁 耳鸣、头晕、心悸7个月。伴失眠、纳差、记忆力减退,体重减轻明显。查体:神志清,体型消瘦,言语流利,双侧耳鸣,听力差,双侧眼底动脉硬化,心音低钝,腹软,上腹部轻度压痛。心电图示T波低平。电测听双耳听力减退。诊断患慢性脑供血不足,服用本发明中药制剂三个疗程后,复查心电图正常,电测听双耳听力基本恢复正常,患者食欲增加,体重较治疗前增加3公斤,头晕、心悸症状消失,记忆力改善,睡眠良好。
6.董X,女,69岁 头沉、头晕2年,加重3天。伴有心悸、畏寒、疲乏感、失眠。查体:Bp165/80mmHg,神志清,心音低钝,偶闻及早搏,双肺呼吸音粗,腹软,四肢皮温低。心电图示室性早搏。微循环检查示四肢微循环障碍。确诊患慢性脑供血不足,服用本发明中药制剂三个疗程后,复查心电图、微循环均正常。患者未再出现头沉、头晕症状,精力较治疗前充沛,畏寒、失眠症状消失。
Claims (1)
1.一种治疗慢性脑供血不足的中药制剂,其特征在于,由以下中药加工配制而成:黄芪30克、葛根15克、桑寄生15克、丹参30克、生山楂9克、川芎9克、桂枝10克、麦冬12克、五味子6克、炒枣仁15克;取上述重量原料中药,经炮制后加1000ml水煎煮,药汁浓缩至200ml时捞渣过滤制成汤剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110193821 CN102266481B (zh) | 2011-06-30 | 2011-06-30 | 一种治疗慢性脑供血不足的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110193821 CN102266481B (zh) | 2011-06-30 | 2011-06-30 | 一种治疗慢性脑供血不足的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102266481A CN102266481A (zh) | 2011-12-07 |
CN102266481B true CN102266481B (zh) | 2013-03-27 |
Family
ID=45049062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110193821 Expired - Fee Related CN102266481B (zh) | 2011-06-30 | 2011-06-30 | 一种治疗慢性脑供血不足的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102266481B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105214062A (zh) * | 2015-11-10 | 2016-01-06 | 济南舜祥医药科技有限公司 | 一种用于治疗脑供血不足的中药汤剂 |
CN105214061A (zh) * | 2015-11-10 | 2016-01-06 | 济南舜祥医药科技有限公司 | 一种治疗慢性脑供血不足的药物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612223A (zh) * | 2008-06-26 | 2009-12-30 | 崔艳 | 一种益心健脑的中药 |
-
2011
- 2011-06-30 CN CN 201110193821 patent/CN102266481B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612223A (zh) * | 2008-06-26 | 2009-12-30 | 崔艳 | 一种益心健脑的中药 |
Also Published As
Publication number | Publication date |
---|---|
CN102266481A (zh) | 2011-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100435831C (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN102614387B (zh) | 预防和治疗脑中风的中药组合及制备方法 | |
CN103877263A (zh) | 一种红参、玛咖、绿茶提取物(茶氨酸)等复合中药抗疲劳养生制剂 | |
CN102772704B (zh) | 老年病药物 | |
CN101716242B (zh) | 一种治疗心脑血管疾病的中药 | |
CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
CN103202879B (zh) | 一种治疗慢性心力衰竭的中药组合物及制备方法 | |
CN103211930A (zh) | 一种降血脂、降血压的中药制剂 | |
CN103479969B (zh) | 一种治疗癫狂病的药物及其制备方法 | |
CN103041119B (zh) | 一种治疗心脏病的中药 | |
CN102114231A (zh) | 一种治疗心律失常的药物 | |
CN102266481B (zh) | 一种治疗慢性脑供血不足的中药制剂 | |
CN104083438A (zh) | 一种缓解高血压的苦瓜中药制剂及制备方法 | |
CN101549078A (zh) | 一种用于治疗顽固性失眠的药物组合及其制备方法 | |
CN103893670A (zh) | 一种治疗心脑血管病的中药药丸 | |
CN102614460B (zh) | 治疗心肌梗塞的中药组合物及其制备方法 | |
CN102614462B (zh) | 治疗冠心病的中药组合物及其制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN103920102A (zh) | 一种治疗原发性低血压的中药药物 | |
CN102579688B (zh) | 菊麻降压中药制剂 | |
CN102614459B (zh) | 快速治疗心肌缺血的中药喷雾剂及其制备方法 | |
CN102614461A (zh) | 快速缓解心绞痛的喷雾剂及其制备方法 | |
CN103330911B (zh) | 治疗冠心病的中药组合物粉剂及其制备方法 | |
CN102772665B (zh) | 一种治疗阴虚内热型病毒性心肌炎的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130327 Termination date: 20160630 |
|
CF01 | Termination of patent right due to non-payment of annual fee |